INMD

+ Watchlist + Portfolio

InMode Ltd.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $15.04
52-Week Range: $12.72 – $16.74
Market Cap: $858.56M
P/E (TTM): 12.33
EPS (TTM): 1.21
Dividend Yield: —

Advanced Metrics

Price/Book: 1.40
PEG Ratio: 0.83
Return on Equity: 12.33%
Return on Assets: 6.17%
Gross Margin: 76.52%
Operating Margin: 12.82%
Profit Margin: 20.69%
Current Ratio: 8.18
Debt/Equity: 0.01
Total Debt: $4.45M
Free Cash Flow: $47.40M
Revenue Growth: 0.00%
Earnings Growth: -31.00%
Enterprise Value: $382.17M

INMD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$454.27M	$492.05M	$394.82M	$370.50M
Cost of Revenue	$73.48M	$80.71M	$77.75M	$79.53M
Gross Profit	$380.79M	$411.34M	$317.07M	$290.97M
Research & Development	$12.43M	$13.41M	$13.14M	$13.32M
Selling, General & Admin	$170.51M	$202.27M	$191.40M	$192.26M
Operating Expenses	$182.93M	$215.68M	$204.53M	$205.58M
Operating Income	$197.85M	$195.66M	$112.53M	$85.39M
EBITDA	$198.53M	$196.28M	$113.26M	$86.08M
Pretax Income	$201.47M	$217.27M	$143.47M	$110.33M
Income Tax	$39.95M	$19.35M	-$37.81M	$16.50M
Net Income	$161.52M	$197.92M	$181.28M	$93.83M
Diluted EPS	1.89	2.30	2.25	1.43
Diluted Shares	85.40M	85.95M	80.60M	65.44M

INMD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$97.54M	$144.41M	$155.33M	$302.54M
Receivables	$28.27M	$43.63M	$41.05M	$49.28M
Inventory	$39.90M	$45.09M	$59.55M	$74.05M
Current Assets	$629.37M	$845.33M	$714.45M	$698.62M
Total Assets	$644.41M	$863.29M	$785.67M	$766.43M
Current Liabilities	$82.02M	$64.14M	$69.85M	$70.74M
Total Debt	$4.96M	$9.02M	$7.82M	$8.23M
Total Liabilities	$89.79M	$75.91M	$81.85M	$83.23M
Retained Earnings	$495.51M	$693.43M	$874.70M	$968.53M
Shareholders' Equity	$554.62M	$787.37M	$703.81M	$683.20M
Working Capital	$547.35M	$781.19M	$644.60M	$627.88M

INMD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$181.58M	$176.83M	$132.66M	$85.26M
Capital Expenditure	-$1.57M	-$705.00K	-$669.00K	-$972.00K
Free Cash Flow	$180.00M	$176.12M	$132.00M	$84.28M
Depreciation & Amortisation	$680.00K	$623.00K	$728.00K	$695.00K
Stock-Based Compensation	$24.45M	$23.60M	$16.57M	$11.13M
Investing Cash Flow	-$109.47M	-$136.06M	$162.21M	$186.03M
Financing Cash Flow	-$41.09M	$5.50M	-$282.77M	-$126.06M
Share Repurchases	-$42.64M	$0.00	-$285.38M	-$127.44M
Net Change in Cash	$31.02M	$46.27M	$12.10M	$145.23M

INMD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$77.87M	$95.60M	$93.17M	$103.85M	$82.02M
Cost of Revenue	$16.96M	$19.15M	$20.86M	$22.55M	$20.46M
Gross Profit	$60.91M	$76.45M	$72.31M	$81.30M	$61.55M
Research & Development	$2.90M	$3.37M	$3.54M	$3.51M	$3.54M
Selling, General & Admin	$42.40M	$50.20M	$47.87M	$51.80M	$47.95M
Operating Expenses	$45.29M	$53.57M	$51.41M	$55.31M	$51.50M
Operating Income	$15.62M	$22.88M	$20.90M	$25.99M	$10.06M
EBITDA	$15.79M	$23.07M	$21.05M	$26.16M	$10.23M
Pretax Income	$22.48M	$30.94M	$25.62M	$31.29M	$14.35M
Income Tax	$4.28M	$4.20M	$3.75M	$4.27M	$2.79M
Net Income	$18.20M	$26.74M	$21.86M	$27.02M	$11.56M
Diluted EPS	0.26	0.42	0.34	0.42	0.18
Diluted Shares	69.44M	63.64M	63.87M	64.08M	63.94M

INMD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$145.95M	$216.24M	$252.44M	$302.54M	$394.30M
Receivables	$57.93M	$59.99M	$62.58M	$49.28M	$72.21M
Inventory	$63.78M	$68.11M	$71.40M	$74.05M	$71.41M
Current Assets	$634.64M	$638.78M	$666.29M	$698.62M	$680.78M
Total Assets	$704.74M	$708.35M	$734.61M	$766.43M	$750.84M
Current Liabilities	$72.66M	$66.53M	$68.33M	$70.74M	$77.35M
Total Debt	$5.59M	$6.10M	$5.59M	$8.23M	$4.83M
Total Liabilities	$85.31M	$79.91M	$81.22M	$83.23M	$89.58M
Retained Earnings	—	—	—	$968.53M	—
Shareholders' Equity	$619.43M	$628.44M	$653.38M	$683.20M	$661.25M
Working Capital	$561.98M	$572.25M	$597.96M	$627.88M	$603.43M

INMD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$14.04M	$24.07M	$24.47M	$22.67M	$15.39M
Capital Expenditure	-$85.00K	-$219.00K	-$134.00K	-$534.00K	-$172.00K
Free Cash Flow	$13.96M	$23.85M	$24.33M	$22.14M	$15.21M
Depreciation & Amortisation	$174.00K	$191.00K	$156.00K	$174.00K	$175.00K
Stock-Based Compensation	$2.52M	$3.42M	$2.70M	$2.50M	$2.70M
Investing Cash Flow	$75.48M	$71.66M	$11.67M	$27.22M	$109.10M
Financing Cash Flow	-$99.47M	-$26.98M	$249.00K	$137.00K	-$32.43M
Share Repurchases	-$99.96M	-$27.48M	$0.00	$0.00	-$31.24M
Net Change in Cash	-$9.94M	$68.75M	$36.38M	$50.03M	$92.06M

Market Snapshot

About

InMode Ltd. is a global provider of innovative medical technologies focused on minimally invasive and non-invasive aesthetic and surgical solutions. The company develops, manufactures, and markets energy-based medical devices for plastic surgery, dermatology, gynecology, and ophthalmology procedures. InMode's product portfolio includes radiofrequency and laser-based platforms for body contouring, facial rejuvenation, skin tightening, and women's health applications. The company's devices are used by physicians and aesthetic practitioners in over 90 countries, combining clinical efficacy with patient comfort and minimal downtime.